Detail akcie Boiron SA online

Business Summary: Boiron SA is a France-based pharmaceutical company engaged in the provision of homeopathic medicines. The Company develops, manufactures and markets single homeopathic medicines and drugs which are in the form of tablets, syrups, single-dose liquids and ointments. It also produces medicines based on trace elements, phytotherapy remedies, food supplements, as well as health and beauty care products. In addition, the Company owns a research center, which works for the development of homeopathy within the world of medicine. Boiron SA operates through a number of subsidiaries, which are based in Italy, Spain, Belgium, the Czech Republic, Slovakia, Russia, Romania, Poland, Hungary, the United States, Canada and Brazil, among others.
Financial Summary: BRIEF: For the six months ended 30 June 2025, Boiron SA revenues increased 8% to EUR245.6M. Net income applicable to common stockholders increased from EUR3.3M to EUR11.4M. Revenues reflect OTC Specialities and Other Products segment increase of 17% to EUR149.3M, North America segment increase of 23% to EUR73M, Other Countries segment increase of 62% to EUR15.7M, France segment increase of less than 1% to EUR102.2M.